{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:35:56Z","timestamp":1793144156288,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,16]]},"DOI":"10.1093\/ibd\/izy065","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T15:34:40Z","timestamp":1534433680000},"page":"1876-1882","source":"Crossref","is-referenced-by-count":70,"title":["Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"24","author":[{"given":"Marla C","family":"Dubinsky","sequence":"first","affiliation":[{"name":"Icahn School of Medicine, Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond K","family":"Cross","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Sandborn","sequence":"additional","affiliation":[{"name":"University of California San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Long","sequence":"additional","affiliation":[{"name":"Universtiy of North Carolina, Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Song","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianwen","family":"Shi","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ding","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Eichner","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandee","family":"Pappalardo","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Ganguli","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Wang","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"key\n\t\t\t\t20180816113425_CIT0001","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3393\/jksc.2012.28.3.121","article-title":"A comprehensive review of inflammatory bowel disease focusing on surgical management","volume":"28","author":"Baik","year":"2012","journal-title":"J Korean Soc Coloproctol"},{"key":"key\n\t\t\t\t20180816113425_CIT0002","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3748\/wjg.v17.i22.2723","article-title":"Comorbidity in inflammatory bowel disease","volume":"17","author":"Rom\u00e1n","year":"2011","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180816113425_CIT0003","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"Ardizzone","year":"2008","journal-title":"Dig Liver Dis"},{"key":"key\n\t\t\t\t20180816113425_CIT0004","first-page":"235","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"7","author":"Levine","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key\n\t\t\t\t20180816113425_CIT0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management","volume":"42","author":"Larsen","year":"2010","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t20180816113425_CIT0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ibd.21371","article-title":"Utilization of healthcare resources by U.S. Children and adults with inflammatory bowel disease","volume":"17","author":"Kappelman","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180816113425_CIT0007","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"Trikudanathan","year":"2012","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180816113425_CIT0008","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180816113425_CIT0009","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180816113425_CIT0010","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1053\/j.gastro.2008.07.069","article-title":"Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn\u2019s disease: results from the Charm study","volume":"135","author":"Feagan","year":"2008","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180816113425_CIT0011","first-page":"559","article-title":"Intravenous versus subcutaneous anti-TNF-alpha agents for Crohn\u2019s disease: a comparison of effectiveness and safety","volume":"21","author":"Liu","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"key\n\t\t\t\t20180816113425_CIT0012","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/MIB.0000000000000139","article-title":"A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases","volume":"20","author":"van Deen","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180816113425_CIT0013","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/157339512800099666","article-title":"Integrin \u03b14\u03b27 antagonists: activities, mechanisms of action and therapeutic prospects","volume":"8","author":"Soler-Ferran","year":"2012","journal-title":"Curr Immunol Rev"},{"key":"key\n\t\t\t\t20180816113425_CIT0014","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1756283X16635081","article-title":"The role of vedolizumab in patients with moderate-to-severe Crohn\u2019s disease and ulcerative colitis","volume":"9","author":"Shahidi","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"key\n\t\t\t\t20180816113425_CIT0015","first-page":"147","article-title":"Designing biologic selectivity for inflammatory bowel disease\u2013role of vedolizumab","volume":"9","author":"Krupka","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key\n\t\t\t\t20180816113425_CIT0016","author":"Hansen","year":"2016"},{"key":"key\n\t\t\t\t20180816113425_CIT0017","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2009.02.001","article-title":"Biological therapies for inflammatory bowel diseases","volume":"136","author":"Rutgeerts","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180816113425_CIT0018","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11894-008-0108-6","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"10","author":"Williams","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"key\n\t\t\t\t20180816113425_CIT0019","first-page":"1932","article-title":"Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis","volume":"25","author":"Elewaut","year":"1998","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20180816113425_CIT0020","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/annrheumdis-2016-210233","article-title":"An induction or flare of arthritis and\/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series","volume":"76","author":"Varkas","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"key\n\t\t\t\t20180816113425_CIT0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jbspin.2017.01.012","article-title":"Arthritis occurrence or reactivation under vedolizumab treatment for inflammatory bowel disease: a four cases report","volume":"85","author":"Wendling","year":"2018","journal-title":"Joint Bone Spine"},{"key":"key\n\t\t\t\t20180816113425_CIT0022","author":"Rubin","year":"2016"},{"key":"key\n\t\t\t\t20180816113425_CIT0023","volume-title":"Adalimumab Treatment Reduces Extraintestinal Manifestations in Patients With Moderate-to-severe Crohn\u2019s Disease: A Pooled Analysis","author":"Louis","year":"2016"},{"key":"key\n\t\t\t\t20180816113425_CIT0024","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/24\/9\/1876\/25502265\/izy065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T11:43:55Z","timestamp":1571744635000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/24\/9\/1876\/4969986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,4,13]]},"published-print":{"date-parts":[[2018,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izy065","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,4,13]]}}}